LVAD Program

At NYU Langone’s LVAD Program, we offer leading edge, lifesaving mechanical circulatory support for two major conditions: acute cardiogenic shock, in which the heart muscle abruptly stops working, and chronic advanced heart failure, in which the heart muscle is permanently weakened and doesn’t pump blood and oxygen throughout the body efficiently.

After someone experiences acute cardiogenic shock, an LVAD, also known as a left ventricular assist device, helps circulate blood throughout the body. In chronic heart failure, an LVAD can help extend—and improve—the lives of some people, whether you are awaiting a heart transplant or you are not a candidate for one. This treatment has been shown to increase patient survival, sometimes by more than five years.

Through the LVAD Program, experts at NYU Langone Heart offer devices approved by the U.S. Food and Drug Administration for treating advanced heart failure. Our LVAD Program has earned advanced certification from The Joint Commission, in recognition of our commitment to safety and protocols in support of positive patient outcomes.

LVAD procedures take place at the Kimmel Pavilion in Manhattan and NYU Langone Hospital—Long Island in Mineola. Our team of heart failure cardiologists and cardiac surgeons, nurse practitioners, social workers, and other specialists work together to provide personalized care before, during, and after surgery to place an LVAD. Our experts are available 24 hours a day, 7 days a week, through our dedicated hotline, and we monitor your progress daily to ensure that you are safely taking medications and making lifestyle changes designed to improve your overall health.